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In the embryonic mouse retina, retinoic acid (RA) is unevenly distributed along the dorsoventral axis: RA-rich zones in dorsal and ventral
retina are separated by a horizontal RA-poor stripe that contains the RA-inactivating enzyme CYP26A1. To explore the developmental role
of this arrangement, we studied formation of the retina and its projections in Cyp26a1 null-mutant mice. Expression of several dorsoventral
markers was not affected, indicating that CYP26A1 is not required for establishing the dorsoventral retina axis. Analysis of the mutation on a
RA-reporter mouse background confirmed, as expected, that the RA-poor stripe was missing in the retina and its projections at the time when
the optic axons first grow over the diencephalon. A day later, however, a gap appeared both in retina and retinofugal projections. As
explanation, we found that CYP26C1, another RA-degrading enzyme, had emerged centrally in a narrower domain within the RA-poor
stripe. While RA applications increased retinal Cyp26a1 expression, they slightly reduced Cyp26c1. These observations indicate that the two
enzymes function independently. The safeguard of the RA-poor stripe by two distinct enzymes during later development points to a role in
maturation of a significant functional feature like an area of higher visual acuity that develops at its location.
D 2004 Elsevier Inc. All rights reserved.
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Retinoic acid (RA), the major active derivative of vi-
tamin A, plays critical roles in growth, differentiation,
morphogenesis, and homeostasis (Mark and Chambon,
2003). The eye stands out in retinoid dependency: ocular
malformations are the most sensitive indicators of vitamin
A deficiency during development (Hale, 1937), and the
use of retinaldehyde as visual chromophore makes the
retina the organ with by far highest retinoid concentration0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.08.032
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E-mail address: Ursula.Drager@umassmed.edu (U.C. Dr7ger).in the adult (Saari, 1994). RA transduces its signaling by
binding to ligand-activated nuclear transcription factors,
the RARs and RXRs (Chambon, 1996; Sucov and Evans,
1995). When RA is present, expression of its target genes
is regulated by different combinations of RAR/RXR
heterodimers (Kastner et al., 1997). In addition to the
presence of RA, also its absence can be critical for the
regulation of gene expression by the RA receptors. For
instance, a repressive function of unliganded RARs is
essential for proper head formation in early embryos
(Koide et al., 2001; Weston et al., 2003). The local levels
of RA are determined by two types of enzymes, the RA-
synthesizing retinaldehyde dehydrogenases (RALDHs) and
RA-degrading members of the cytochrome P450-linked
oxidase family, the CYP26 enzymes (Maden, 2002). In
humans and mice, four RALDHs and three CYP26s have276 (2004) 143–157
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1991; Li et al., 2000; Lin et al., 2003; Suzuki et al., 2000;
Zhao et al., 1996) and CYP26A1, B1, and C1 (Abu-Abed
et al., 2002; Fujii et al., 1997; MacLean et al., 2001; Ray
et al., 1997; Tahayato et al., 2003; Taimi et al., 2004;
White et al., 1996). As RA can diffuse freely across solid
tissues, the local expression sites of the metabolic
enzymes represent potential spatial patterning tools: the
RALDHs form the origins of RA diffusion gradients and
the CYP26s generate abrupt steps in RA levels.
RA synthesis in the future eye region of the mouse
begins with neurulation at embryonic day 8 (E8), when
Raldh2 is transiently expressed at the anterior neural ridge,
an organizing center for both eye and forebrain formation
(Wagner et al., 2000; Wilson and Rubenstein, 2000). At
E8.5, Raldh3 expression starts in the surface epidermis over
the optic recess, and a day later, it appears in the ventral
neural retina, the dorsal retinal pigment epithelium, and the
lens (Gru¨n et al., 2000; Li et al., 2000; Suzuki et al., 2000).
At E9, Raldh1 and Cyp26a1 begin to be expressed in
overlapping regions of the dorsal eye vesicle (Wagner et al.,
2000). Raldh1 expression then remains in the dorsal retina,
whereas Cyp26a1 moves downwards to form a horizontal
stripe across the neural retina underneath RALDH1. By
E11.5, the embryonic retina is subdivided into three zones
of different RA levels along the dorsoventral axis: mode-
rately high RA levels generated dorsally by RALDH1 and
very high RA levels made ventrally by RALDH3 are
separated by a horizontal RA-poor stripe that is created by
CYP26A1 activity (McCaffery et al., 1999). These three
compartments of different RA levels are directly visible in
RA-reporter mice that are transgenic for a construct
containing lacZ driven by sensitive RA response elements
(Rossant et al., 1991): in these mice, the ganglion-cell axons
from the dorsal and ventral lacZ-positive retina regions are
intensely labeled all along their projections to the optic
targets in the brain (Wagner et al., 2000).
The zones of RA synthesis in the eye of embryonic
vertebrates match with other molecular markers of the
dorsoventral retinal axis; for example, the dorsal tran-
scription factor Tbx5 overlaps with Raldh1 expression and
the ventral transcription factor Vax2 with Raldh3 (Peters,
2002). Whereas the partition of the developing eye into
dorsal and ventral compartments is very ancient, however,
an involvement of RA in this pattern is much more recent:
although the genome of Drosophila does not contain RA
receptors, the eye disc in embryonic flies is subdivided
into dorsal, equatorial, and ventral zones by multiple
patterning factors (Brodsky and Steller, 1996). In adult
flies, this embryonic pattern gives rise to the morpholog-
ically distinct dorsal and ventral divisions of the compound
eye, which are separated by a horizontally oriented border
region. Similarly in mice, the coordinates of the embryonic
eye are already the same as those used for functional
vision; that is, the eye is not formed in the segmental
scheme in which the rest of the nervous system is set up inthe embryo, but the coordinates for its morphogenesis
predict the light distribution falling onto the retina in the
functional eye (Wagner et al., 2000). In contrast to the
ancient mechanisms for dorsoventral eye formation, the
use of RA as transcriptional regulator emerged only in
chordates/vertebrates, and it often functions as a new layer
of regulation superimposed over older processes (Escriva
et al., 2000).
This discrepancy in evolutionary age between dorso-
ventral eye formation and transcriptional use of RA is
probably related to variations between vertebrates in the
extent to which RA is able to influence formation of the
dorsoventral retina. In zebrafish, perturbations in RA levels
have the most pronounced effect: RA deficiency abolishes
the ventral retina (Marsh-Armstrong et al., 1994), and RA
excess duplicates it at the expense of the dorsal retina
(Hyatt et al., 1996). In mice, the effects are milder: genetic
null-mutants of the dorsal Raldh1 enzyme have no
detectable eye defect (Fan et al., 2003), and null-mutants
of the ventral Raldh3 only cause reductions in the size of
the ventral retina (Dupe et al., 2003). A similar reduction
in ventral-retina size is also one of the effects of vitamin A
deficiency in rodents (Warkany and Schraffenberger,
1946), and it can be caused by genetic disruptions of
several RA receptors (Mark and Chambon, 2003). In the
chick, expression of the metabolic enzymes in the eye
region begins later than in the mouse, and the shape of its
eye is relatively impervious to experimental RA perturba-
tions (Mey et al., 2001).
Here, we used Cyp26a1 null-mutants to ask whether the
RA-poor stripe generated by CYP26A1 is required for
morphogenesis of the embryonic retina and its projections
to the brain in mice. While CYP26A1 was previously the
only RA-degrading enzyme identified in the neural retina
of the mouse, we found that its lack abolished the RA-poor
stripe only transiently during early formation of the
retinofugal projections. A little later, the stripe became
partially visible, but it was now generated by CYP26C1,
another RA-degrading enzyme. Thus, both CYP26A1 and
CYP26C1 cooperate to establish a RA-poor stripe during
later retina development, which makes it likely that it is
necessary for formation of a functionally important feature,
such as a retinal region specialized for higher acuity
vision.Materials and methods
Mice
The production of the Cyp26a1- and Cyp26b1-null mice
and the polymerase chain reaction (PCR) strategies for
detection of their genotypes were described previously
(Sakai et al., 2001; Yashiro et al., 2004). The breeding
colony of the RARE-hsplacZ reporter mice was a gift from J.
Rossant (Rossant et al., 1991). The embryos were staged
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conducted following procedures approved by the recom-
mendations of the Panel on Euthanasia of the American
Veterinary Medical Association.
In situ hybridization
In situ hybridizations on whole mounts and sections were
performed according to previously published protocols
(Henrique et al., 1995; McCaffery et al., 1999). The probe
for Vax2 (Schulte et al., 1999) was provided by T. Furukawa
and the one for Tbx5 (Koshiba-Takeuchi et al., 2000) by T.
Ogura. Probes for Raldh1, Raldh3, Cyp26a1, and Cyp26b1
were prepared as described (Fujii et al., 1997; Li et al.,
2000; Yashiro et al., 2004). A probe for Cyp26c1 was
generated to the nucleotide residues 360–855 of the mouse
Cyp26c1 cDNA.
RA administration
For the RA applications, aliquots from a stock solution of
0.1 M all-trans RA (Sigma) in dimethyl sulfoxide (DMSO)
were emulsified in tissue culture medium containing 10%
fetal calf serum and injected intraperitoneally (Luo et al.,
2004). RA doses were adjusted to the weight of the mouse
at 30 mg/kg for pups, a dose that is close to the LD50 at this
age (Luo et al., in preparation), and 60 mg/kg in pregnant
mice, a high yet not toxic dose for adults.
b-Galactosidase staining
For whole-mount staining of RA-reporter tissues, the
dissected samples were fixed in 0.2% glutaraldehyde and
processed following Rossant et al.’s (1991) protocol. For
sections, the embryos were briefly perfused transcardially
with 2% glutaraldehyde. The heads or brains were rapidly
embedded in 4% agarose, sliced at 150 Am on a vibratome,
and the slices were processed with 5-bromo-4-chloro-3-
indolyl-h-d-galactopyranoside (X-gal) for lacZ visualiza-
tion (Luo et al., 2004).
DiI labeling
The optic projections were traced in E15.5–18.5
embryos with DiI (1,1-dioctadecyl-3,3,3V,3V-tetramethylin-
docarbocyanine perchlorate; Molecular Probes), following
a protocol provided by Pierre Godement (Godement et
al., 1987). All embryos in litters from heterozygous
Cyp26a1+/ matings were perfused transcardially with
4% paraformaldehyde in phosphate-buffered saline (PBS)
and stored for one to several days in the same fixative.
Then one eye was carefully packed with homogenized
DiI crystals, and the embryos were stored in PBS at
room temperature. After 6–8 weeks, the optic pathways
were dissected and photographed with epifluorescence
optics on a Zeiss Axioplan.Results
Dorsoventral markers
In the normal embryonic retina, Cyp26a1 occupies a
horizontal stripe region that abuts the dorsal and ventral
RALDH territories (McCaffery et al., 1999). To test whether
this arrangement signals a flexible state that is responsive to
local RA levels, we examined the expression patterns of
several dorsoventral marker genes in Cyp26a1 null-mutants.
The transcription factor T-box5 (Tbx5) is an early marker for
the dorsal retina and the ventral anterior homeobox gene
(Vax2) for the ventral retina in mice and chicken (Koshiba-
Takeuchi et al., 2000; Schulte et al., 1999). In situ
hybridizations on whole mounts and sections of mutant
and wild-type embryos revealed no differences in the
expression pattern of either Tbx5 or Vax2 at E9.5 to
E14.5, the ages tested. In the double-labeled preparations
shown here (Fig. 1A), the two markers are separated by a
gap that is the same in normal and mutant embryos.
Similarly, the expressions of Raldh1 and Raldh3 are not
affected in the Cyp26a1/ retina (Fig. 1B). These results
indicate that generation of the RA-poor stripe is not essential
for patterning the retina along its dorsoventral axis.
Altered expression of a RA-reporter in Cyp26a1/ mice:
local and systemic effects
RA reporter animals, including the RARE-hsplacZ mice
made by Rossant et al. (1991), are widely used as indicators
of endogenous RA signaling. Their lacZ expression patterns
reflect combinations of local RA levels and of propensities to
respond to RA. For instance, in the RALDH-rich retina, the
lacZ patterns signal mainly the RA distribution, whereas in
brain tissue that receives most of its RA by diffusion the lacZ
labeling marks primarily RA-responsive sites (Luo et al.,
2004). To visualize directly the effects of eliminating
CYP26A1 activity, we crossed the RARE-hsplacZ transgene
(Rossant et al., 1991) onto the Cyp26a1 mutant stock. The
heads or brains of perfusion-fixed embryos were serially
sliced on a vibratome at 150 Am and reacted with X-gal for
lacZ expression. The coronal section (Fig. 2A) through the
eyes of an E15 homozygous Cyp26a1/ mutant embryo
shows that the gap between dorsal and ventral retina is
missing, while it is readily visible in the slice through eyes of
a normal embryo (Fig. 2B).
In addition to this local effect in the retina where
CYP26A1 is normally present, the Cyp26a1/ mutation
exerted a widespread intensification of lacZ staining at
many sites, at most of which CYP26A1 is never expressed;
this was immediately obvious when all slices of mutant
and normal heads were viewed side by side. In the
illustrated rostral sections (Figs. 2A, B), the cornea,
conjunctiva, and frontonasal region are abnormally heavily
labeled in the mutant compared to the normal embryo. In
the brain, the general intensification was most pronounced
Fig. 1. (A) In situ hybridizations on whole heads of Cyp26a1/ embryos and normal littermates labeled with two probes simultaneously, one to the dorsal-
retina marker Tbx5 and the other to the ventral marker Vax2. (B) Paraffin-sectioned heads double-labeled for dorsal Raldh1 and ventral Raldh3 mRNA. Here,
as in all following figures, dorsal is up and ventral down. Note that the spatial layout of the dorsoventral retina markers in the mutants is similar to the normal
patterns. E10.5: embryonic day 10.5.
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expressed here or anywhere else in the forebrain. The
comparison of slices through mutant (Fig. 2C) and normal
brains (Figs. 2E, F) shows an increase in overall lacZ
labeling, which is conspicuous even over the normally
somewhat variable lacZ labeling of the cortex (Luo et al.,
2004). The lacZ intensification in the Cyp26a1/ mutants
resembles delayed effects in the cortex to earlier RA
injections (Fig. 2D): when embryos are exposed to RA
excess early in telencephalon development, the RA-
reporter expression in the cerebral cortex can undergo a
lasting change that appears like a sensitization to endog-
enous RA levels and that is similar to changes observed in
the di- and mesencephalon after specific injection times
(Luo et al., 2004). Although we do not know the functional
significance of this phenomenon, we have observed it in
the cortex only following RA injections around E10–11 but
not after earlier or later applications. Here, we take this
observation as indicator for generalized and chronic RA
poisoning of the Cyp26a1/ mutants in addition to the
local consequences of the mutation. Although Cyp26a1 is
expressed only at restricted locations in the embryo,
including the retina, hindbrain and tail, elimination of the
gene thus also influences the circulating RA levels and the
general retinoid homeostasis.
The RA reporter indicates CYP26A1 dosage and a residual
gap
To evaluate the effects of altered CYP26A1 levels on
the retinas and their central projections in entirety, weprepared whole mounts of the brains and corresponding
retinas separately for each embryo in litters from hetero-
zygous Cyp26a1+/ matings, and we determined the
individual genotypes by PCR. From the brains, the
telencephala and hindbrains were removed, and the
remaining di- and mesencephala were flattened by a cut
along the ventral midline (Luo et al., 2004). In the
preparations illustrated (Figs. 3A–C), the optic tract is
visible as it projects in form of a tight bundle from the
optic chiasm (ox, left in the figures) across the hypothala-
mic surface of the diencephalon. Beginning at the rostral
border of the lateral geniculate nucleus (lgn), the optic
axons then splay out to cover the central retinotopic maps,
in which the ventral retina (V) is represented dorsomedially
in the geniculate and the dorsal retina (D) ventrolaterally.
In the wild-type embryos (+/+, Fig. 3), the axon
bundles from dorsal and ventral retina are separated by
an unlabeled gap that we assume contains unlabeled
axons from the CYP26A1 stripe in the retina. In the
preparations of the E15 litter shown, absence of all
CYP26A1 activity in the (/) mutants has completely
eliminated the gap in the retinofugal projections (Fig.
3A), as well as the RA-free stripe in the retinas (Fig.
3D); in the heterozygous E15 Cyp26a1+/ mutants, the
RA-free stripe in the retinas is partially obliterated, and
the gap in the diencephalic optic projection is partly
filled in. Surprisingly, in the homozygous Cyp26a1/
mutant embryo of the E17.5 litter (Fig. 3B), the optic
projections are separated by a partial gap in the
diencephalon (see red arrow), which is less pronounced
than in the heterozygous projections but still clearly
Fig. 2. X-gal reacted slices through embryonic heads to illustrate the effects of the Cyp26a1/ mutation on RA-reporter expression, as described in the text.
Note that the lacZ labeling of the mutant retinas (A) is continuous, whereas in normal retinas it is interrupted by a gap (B). In addition to the effects on the
neural retina, the Cyp26a1/ mutation results in an intensification of lacZ expression at selected locations including the cornea (corn.) and conjunctiva (conj.)
of the eye, the frontonasal region (A), and the occipital cortex (C). Systemic RA injections cause acutely a similar increase in lacZ expression in the retina (Luo
et al., 2004) and chronically in the cortex (compare D with E, F). The embryo in D had been exposed to 30 mg/kg all-trans RA at E10.5, and it was perfused at
E16.5.
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E18.5 litter (Fig. 3C), for which also several retinas are
illustrated (Fig. 3E): in the homozygous Cyp26a1/
mutant embryos, a region of reduced lacZ expression is
visible both in the retinas and optic projections (red arrows),
and in the heterozygous (+/) mutants, the retina stripe and
central gap are narrower compared to the wild-type embryo.Comparisons of Cyp26a1 expression by in situ hybridization
(Fig. 3F) reveal lower mRNA amounts in heterozygous
Cyp26a1+/ mutant than in wild-type retinas, an observation
that explains the heterozygous effect on the RA-reporter
expression. In the homozygous Cyp26a1/ mutant retinas,
no Cyp26a1 mRNAwas detectable (not shown), leaving the
faint gap in lacZ expression unexplained.
Fig. 3. Flat-mounted di- and mesencephala (A–C) as well as retina cups (D–E) to illustrate the effects of homozygous (/) and heterozygous (+/) Cyp26a1
mutations on RA-reporter expression in the primary optic projections at three ages. The Cyp26a1 genotypes of all embryos were determined by PCR. The in
situ hybridizations for Cyp26a1 on heterozygous (+/) and wild-type (+/+) retinas (F) show a reduction in Cyp26a1 dosage in the heterozygotes. This dosage
effect is directly visible as differences in lacZ expression between heterozygous and wild-type retinas and brains. Note that, at the two older ages, a partial gap
appears in the retinas and retinofugal projections of homozygous Cyp26a1/ mutants (red arrows). Abbreviations: ox, optic chiasm; ot, optic tract; lgn, lateral
geniculate nucleus; V ret, from ventral retina; D ret, from dorsal retina; di, diencephalon; mes, mesencephalon.
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As we began to doubt our previous assumption that the
gap in the retinofugal projections of RA-reporter mice ismerely a consequence of missing reporter expression rather
than a true gap between the projections from dorsal and
ventral retina, we decided to test this question directly. All
embryos in litters of heterozygous matings were perfused
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with the dye DiI, which equilibrates by diffusion within
continuous lipophilic compartments such as axonal mem-
branes, if given enough time (Godement et al., 1987;
Lukas et al., 1998). At all ages tested up to E18.5, no gap
was detectable within the retinofugal projections both in
normal and mutant embryos, as illustrated here (Fig. 4) for
a normal E15 and a mutant E16.5 embryo. When scruti-
nized at higher magnifications, the detailed optic-fiber
trajectories in the mutants were indistinguishable from
normal littermates. This makes it likely that the central
visual maps in the mutant do not have any gross
abnormality, as the optic axons travel largely parallel and
in a topographically ordered arrangement.
Search for another RA-degrading enzyme in the retina
The DiI labelings indicated unambiguously that the
gap in lacZ expression in the older homozygous
Cyp26a1/ mutants must be due to RA degradation in
the retina by a mechanism different from CYP26A1
activity. Two additional RA-degrading enzymes are
known, CYP26B1, which was originally identified as
an expressed sequence tag (EST) in an adult human
retina library (White et al., 2000), and CYP26C1, which
had not been detected in the eye (Tahayato et al., 2003).
We asked whether expression of these two enzymes is
affected in the homozygous Cyp26a1/ mutant embryos,
and we searched for expression in the normal eye region
throughout development. The whole embryos at E9.5–
10.5 (Figs. 5A,B) show no Cyp26b1 or Cyp26c1
expression in the eye regions of the Cyp26a1/ mutants,
like in the wild-type embryos. Outside of the eye, the
normal expression patterns of the two enzymes do notFig. 4. DiI-labeled optic projections in normal embryos and a Cyp26a1/ mutant.
of the labeled axons in the brain is shown in the low-magnification insert of a norm
weaker bundles marked by asterisk are retrogradely labeled motor axons projectiappear grossly altered by the lack in CYP26A1 activity,
as far as is visible by simple inspections of the whole-
mount preparations. For later embryonic ages, we tested
head preparations as well as isolated retinas (Figs. 5C–
H). For Cyp26b1, which we had expected to find, no
trace was detectable at any age in the neural retinas of
normal embryos or of Cyp26a1/ mutants; it is,
however, expressed in the retinal pigment epithelium
(Abu-Abed et al., 2002). As lack of Cyp26b1 is difficult
to illustrate convincingly in isolated retinas, we show
(Fig. 5C) the unlabeled eyes in head-whole mounts next
to positive controls, the emerging whisker follicles. In
screens of Cyp26b1/ null mutants with the same
techniques as described here for Cyp26a1/ embryos,
no changes were apparent in the staining patterns of the
RARE-hsplacZ transgene (data not shown).
Similar to Cyp26b1, no Cyp26c1 was detectable in the
eyes at E11.5 (Fig. 5D). Isolated older retinas, however,
revealed traces beginning around E14. By E15, Cyp26c1
expression had become sufficiently strong to trace a
horizontal line across the retina at a similar position as
the wider Cyp26a1 stripe (Fig. 5E). In the E16 retinal
whole mounts that are shown both from back and front
(Fig. 5F), Cyp26c1 forms a substantial but narrower stripe.
In newborn retinas double-labeled for the RA reporter and
the RA-degrading enzymes, Cyp26c1 occupies the center
of the lacZ-free stripe (Fig. 5G), and Cyp26a1 more or less
fills it (Fig. 5H).
Expression of Cyp26a1 and Cyp26c1 in postnatal retinas
The retinal whole mounts showed that expression of
both Cyp26a1 and Cyp26c1 continues for several days
postnatally, but detection became increasingly difficult inThe telencephala were removed, and rostral is to the left; the general layout
al E16.5 brain. Only the thick fiber bundle consists of optic axons; the two
ng to the eye. Abbreviations: ox, optic chiasm; med, medulla.
Fig. 5. Different preparations to illustrate the absence of Cyp26b1 expression in embryonic retinas (A, C), the expression of Cyp26c1 during later
developmental stages (B, D–G), and comparisons of Cyp26c1 and Cyp26a1 expression (E, G, H). All preparations are in situ hybridizations which, in G and H,
were done following X-gal reactions for the RA-reporter transgene. In F–H, the same retina cups are shown both from back and front. P0.5: postnatal day 0.5.
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section of retinas from normal RA-reporter mice at
successive ages. The retinas were briefly reacted with
X-gal, aligned in the same dorsoventral and nasotemporal
orientation into one block (Fig. 6B), sectioned on a
cryostat, and reacted in parallel to assure optimal
comparability of the in situ hybridization signals. Such
preparations showed that the signal intensities of bothenzymes decrease gradually over the first two postnatal
weeks (Fig. 6A). The Cyp26a1 signal diminished evenly
across the nasotemporal dimension, whereas Cyp26c1
disappeared first in the nasal retina and persisted longest
in the peripheral temporal retina (not illustrated). The
labeled cell bodies become confined to the inner nuclear
layer, as shown for postnatal day 6 (P6) (Fig. 6C). After
about P14, both enzymes became undetectable.
Fig. 6. Sections of normal retinas from RA-reporter mice of different postnatal ages, cut on a cryostat. The retina cups were aligned with help of the lacZ
patterns, stacked together into two blocks, and processed in parallel to assure that the in situ hybridization signals are comparable. The arrows (B) point to the
expression sites of the two Cyp26 enzymes at low magnifications. (A) Enlarged retina segments shown in the same temporal sequence; in the Nomarski view
(C), the retinal layers are indicated. Note that expression of both Cyp26a1 and Cyp26c1 decreases with age and condenses in cell bodies in the inner nuclear
layer (inl); onl, outer nuclear layer; opl, outer plexiform layer; ipl, inner plexiform layer; gcl, ganglion-cell layer; P14, postnatal day 14.
Y. Sakai et al. / Developmental Biology 276 (2004) 143–157 151Responses of Cyp26a1 and Cyp26c1 to RA
As the patterns of Cyp26a1 and Cyp26c1 are similar
in the retina and as the two genes are located very close
together on chromosome 19 (see Discussion), we won-
dered whether expression of the two enzymes is regulated in
a similar way. Cyp26a1 was originally identified as a gene
whose transcription is increased by RA (Ray et al., 1997;
White et al., 1996). To test whether this applies also toCyp26c1, we first compared the normal retinas in hetero-
zygous litters with those of Cyp26a1 mutants, in which the
RA levels are increased. In the homozygous mutant (/)
retina of the E18.5 litter (Fig. 7A), Cyp26c1 expression is
weaker, as compared to the wild-type (+/+) and hetero-
zygous (+/) retinas. A second pregnant Cyp26a1+/
mouse was injected with a very high RA dose (60 mg/kg)
6 h before collection of her embryos at E18.5, and the
retinas were processed in parallel with those from the not-
Fig. 7. Late embryonic and newborn retina cups to illustrate the reactions of Cyp26a1 and Cyp26c1 to altered RA levels. Each vertical panel represents one
experiment; that is, the single retinas in each block are representative of several retinas per batch in a series of different conditions, which were reacted in
parallel to assure perfect comparability of the in situ hybridization signals; a quantitative comparison of signal strength is only possible along the same vertical
block but not between blocks. (A) Retinas from two E18.5 litters of Cyp26a+/ matings. One of the pregnant mice was injected with 60 mg/kg all-trans RA 6 h
before collecting the embryos. The Cyp26a1 genotypes of all embryos were determined by PCR. (B) Retinas of normal newborn mice collected at different
times following injections of 30 mg/kg all-trans RA. Note that RA excess causes a dramatic increase in Cyp26a1 expression and a minor reduction in Cyp26c1
levels. Cyp26c1 expression is stronger in the temporal (T) than nasal retinas (N).
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litters (Fig. 7A) shows that the excessive RA dose causes a
very slight further down-regulation in Cyp26c1 expression
compared to the genetic reduction in CYP26A1. The
intensity of Cyp26a1, by comparison, is drastically in-
creased in the wild-type retina in response to the RA excess,
and in the heterozygous retina, the increase is still striking
but proportionately smaller.
To analyze the time course of the RA effects, we
injected normal newborn pups with 30 mg/kg RA,
collected their retinas at successive times, and reacted all
left retinas for one and the right retinas for the other
enzyme. These experiments show that RA rapidly and
strongly increases Cyp26a1 expression with a maximum
after 6–9 h (Fig. 7B). The RA-induced Cyp26a1
intensification spilled over the normal stripe territory into
the adjoining retina. Cyp26c1, in contrast, is slightlydown-regulated in a slower time course, first visible here
in the 4-h sample. The alignment of all retinas from one
side illustrates that the Cyp26c1 intensity is higher in the
temporal (T) than in nasal (N) retinas. This asymmetry is
consistent with the mentioned longer persistence of
Cyp26c1 in the temporal than nasal retina during the
postnatal signal decline.Discussion
In this study on Cyp26a1 null-mutants, we show that
CYP26A1 and CYP26C1 act in parallel during normal
development to generate a RA-poor stripe in the later
embryonic and early postnatal retina. All Cyp26a1/
mutants are embryonic or perinatal-lethal, with half of the
embryos already dead by E10.5, and only a few
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stages; the heterozygous Cyp26a1+/ mutants are viable
and appear indistinguishable from wild-type mice (Abu-
Abed et al., 2001; Sakai et al., 2001). The homozygous
mutants exhibit severe caudal truncations, defects of
hindbrain patterning and homeotic transformation of
vertebrae, a range of malformations that recapitulate some
of the effects of exposing early embryos to RA excess
(Morriss-Kay and Ward, 1999; Shenefelt, 1972). As in the
previous studies on the Cyp26a1/ mutants no abnor-
malities were detected in the retina that is a major site of
CYP26A1 expression in normal mice, we did now a more
detailed search for defects in the mutant eye and its central
projections with help of a RA reporter, the RARE-hsplacZ
transgene (Rossant et al., 1991). In the homozygous null-
mutants, the RA reporter showed that normally up to
about E15, CYP26A1 is alone responsible for dividing the
retina into three RA-concentration zones, and later its RA-
inactivating function is reinforced by CYP26C1. Cyp26c1
mRNA becomes faintly visible around E14, and over the
following days its expression intensifies. In the mutants
lacking CYP26A1, the remaining CYP26C1 activity
creates by E16.5 a narrower RA-poor stripe that is visible
on the RA reporter background. In the morphologically
normal-appearing heterozygous Cyp26a1+/ mutants, the
sensitive RA-reporter tool did reveal an effect of the
reduced CYP26A1 amount: the lacZ-free stripe was
narrower compared to the wild type; the Cyp26a1
expression stripe, by comparison, was only weaker but
not thinner. This indicates that the width of the lacZ-free
stripe reflects an equilibrium between RA diffusing
tangentially from the dorsal and ventral RALDH-contain-
ing compartments and the catabolic efficiency of the
CYP26 enzymes. Postnatally, the expression of both
Cyp26a1 and Cyp26c1 continues within the inner nuclear
layer for some time but disappears around P14.
Role of RA in eye formation
Normal development of the eye is known to depend on
properly regulated RA levels: microphthalmia was the first
example of congenital malformation found to be induced
by vitamin A deficiency (Hale, 1937), and RA excess can
cause exophthalmia or microphthalmia (Shenefelt, 1972).
The detailed effects of RA perturbations vary to some
extent between different vertebrates, as described above in
the Introduction. In all species, however, where the retinal
RALDH and RA distributions have been analyzed, RA
levels in ventral retina are considerably higher than dorsally
(Gru¨n et al., 2000; Marsh-Armstrong et al., 1994; McCaff-
ery et al., 1993; Mey et al., 1997, 2001).
Knockout mutants have been created for three of the four
Raldh genes and two of the three Cyp26 genes in mice. The
only noticeable gross ocular abnormality in the Cyp26a1/
mutants is a little smaller eye size at early stages compared to
wild type, but this difference becomes less obvious later on.Also inCyp26b1/mutants did we not detect any consistent
abnormalities in the retina and its projections (not illustrated
here). Elimination of the Raldh2 gene causes symptoms of
most severe vitamin A deficiency and is lethal by about E9.5;
the morphology of the eye region at the time of death,
including the expressions of Raldh1 and Raldh3 in it, appears
normal (Mic et al., 2002; Niederreither et al., 1999). The
Raldh1 null-mutants show no apparent defect in the eye or at
any other site, but they are slightly more sensitive to retinol
toxicity (Fan et al., 2003; Molotkov and Duester, 2003).
Raldh3 null-mutants exhibit only mild abnormalities, includ-
ing shortening of the ventral retina with lens rotation,
persistence of the primary vitreous body as retrolenticular
membrane, and absence of Harderian glands (Dupe et al.,
2003). In Raldh1-, Raldh2-, Raldh3-, and Cyp26a1-null
mice, the RARE-hsplacZ reporter shows abnormal RA
distributions in the retina. Dorsoventral retina markers,
however, such as Tbx5 and Vax2, are not affected in any of
the mutants (Dupe et al., 2003; Fan et al., 2003). It can thus be
concluded that the dorsoventral identity of the mouse retina is
determined independently of RA synthesis and that neither
RA itself nor the correct subdivision of the developing retina
into three zones of different RA levels is critical for early eye
formation.
Why then is the developing retina subdivided into three
zones of different RA levels? It is highly unlikely that this
pattern is completely dispensable for normal eye develop-
ment, as it is conserved between vertebrates and as some
of it persists throughout life (McCaffery et al., 1991; Mey
et al., 2001). The question about the functional signifi-
cance of the RA compartments in the retina is part of the
long-standing problem of what determines the location and
timing of RA actions. While initially the expression
patterns of the RA receptors were taken as the natural
candidates for creating the spatial specificity, mouse null-
mutants for almost every single receptor turned out to be
relatively normal (Mark and Chambon, 2003). The
observations that the Raldh2 and Cyp26a1 knockout mice
are much more severely affected than any of the single
receptor null-mutants suggested that the variations in local
RA concentration must be the primary cues for the sites of
RA actions. This explanation, however, is undermined by
the observations that the malformations in RALDH
knockout embryos can be prevented by feeding RA to
the pregnant dams (Dupe et al., 2003; Mic et al., 2002).
The same dietary regimen can even thwart the malforma-
tions caused by severe vitamin A deprivation in early
embryos (White et al., 1998). How can a universal
flooding of the embryo with RA compensate for the
intricate localization patterns of the RALDHs? An
explanation for all these paradoxical observations cannot
be that most of the factors in retinoid actions are
dispensable, but it must be the opposite: RA-mediated
transcriptional regulation apparently matters so much for
survival and normal function that each step is assured by
multiple potentially redundant mechanisms. Neither the
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normal, and the phenotypes of the knockout mice reveal
only parts of the normal functions of particular genes
(Mark and Chambon, 2003). With respect to normal eye
formation and function, the very early event of dorsoven-
tral-axis determination is followed by many different
processes, all of which can include RA-dependent
mechanisms. The high complexity of the retinoid system
and the observations on the null-mutant mice suggest that
mutations in its many different components or down-
stream targets may be involved in multifactorial and
polygenic human diseases.
Relationship of CYP26A1 and CYP26C1
In both mouse and human, the Cyp26a1 and Cyp26c1
genes are located close together and in the same
transcriptional direction, on chromosome 19 and separated
by a 4-kb interval in mice and on chromosome 10 spaced
13 kb apart in humans (Taimi et al., 2004 and
unpublished data). This suggests that one of the genes
has duplicated from the template of the other. A
comparison of the expression patterns of the two genes
makes it likely that Cyp26c1 arose subsequent to
Cyp26a1. It does not seem plausible that the two genes
share a common regulatory system for their expression in
the retina, as all observations indicate that CYP26A1 and
CYP26C1 act independently here. First, there is a
discrepancy in expression regions and stages between
Cyp26c1 and Cyp26a1. Second, in contrast to Cyp26a1,
Cyp26c1 mRNA is not increased in response to RA but is
slightly down-regulated. Third, the human CYP26C1
enzyme was shown to be more efficient in catabolizing
9-cis RA than the other two CYP26s, suggesting a
different physiological role (Taimi et al., 2004). This
relatively higher affinity for 9-cis RA is reminiscent of
the conclusion drawn from many different RA-receptor
knockout mice that ocular morphogenesis is the only siteFig. 8. (A) Visual fields visible to the left and right eyes of a mouse plotted onto a
yellow and red and the binocular field as solid orange. The asterisk indicates the pr
higher from above than below. (C) Approximate domain of maximal visual resoluti
field (Dra¨ger and Hubel, 1976; Dra¨ger and Olsen, 1981).in the body, where the ligand-dependent activation
function of the RXRa—and thus possibly 9-cis RA—is
indispensable (Mark and Chambon, 2003).
What function could justify the reinforced maintenance of a
RA-poor zone in the retina?
We know of no molecular marker whose expression in
the embryonic retina coincides with the CYP26 enzymes,
comparable to the colocalizations of Raldh1 with Tbx5 or
Raldh3 with Vax2. The only feature that colocalizes with
the RA-poor stripe is a horizontally elongated area of
higher visual acuity in the adult mouse (Dra¨ger and Hubel,
1976). A similar area occurs in all mammals, and in its
extreme form, it is called visual streak, as in the rabbit. It is
one of two forms of such visual specializations found in
mammals; the other is the area centralis or fovea in the
temporal retina, which serves focused visual attention. The
visual streak and its equivalents function as specializations
to monitor visual space along the horizon. They are
characterized by anisotropy in their central representations,
such that the vertical dimension of visual space is vastly
enlarged compared to the horizontal dimension in the brain
(Dow et al., 1985; Hughes, 1971; Rosa et al., 1999). In
rabbits, the central anisotropy is very large (approximately
7); in mice and primates, it is comparatively more subtle
(approximately 2).
The visual field of the mouse is illustrated in Fig. 8
(adapted from (Dra¨ger and Hubel, 1976; Dra¨ger and Olsen,
1980)); its geometry reflects the positions of the eyes
placed laterally and on top of the mouse’s head. Fig. 8A
shows the extent of the monocular and binocular fields
projected onto a globe; Fig. 8B shows the most common
light distribution, and Fig. 8C shows the area of highest
visual acuity, which contains also the projection of the area
centralis in the binocular field, which is only very poorly
developed in mice (Dra¨ger and Olsen, 1981). The entire
region of higher visual acuity extends parallel and aboveglobe (Dra¨ger and Olsen, 1980); the monocular fields are drawn as stippled
ojection of the optic disc (=blind spot). (B) Light levels are commonly much
on including the region seen by the area centralis within the binocular visual
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stimulus of interest. This depiction illustrates the similarity
of the visual field to the RA distribution in the embryonic
retina: the RALDH1-expressing region develops into the
dorsal retina onto which the ground projects, the RALDH3
containing region into the retina seeing the sky, and the
CYP26 expression gives rise to the area of highest acuity
or maximal visual attention. The observation described
above that the RA-poor stripe is backed up by two
independent enzymes indicates that development of a
functionally important retinal specialization at its location
depends on very low RA levels such as on the conditions
required for the repressive action of unliganded RA
receptors (Weston et al., 2003).
An anisotropy of visual space similar to the mouse is
apparent psychophysically in humans as optic illusions. For
instance, when an observer is asked to generate histograms
for the orientations of all elongated contours in the visual
surrounding as they project onto his eyes, he finds that all
vertical lines form a tight cluster around the direction of
gravity, whereas the projections of horizontal lines scatter
over a wide range of angles; this phenomenon represents the
perspective view. As any normal environment contains, of
course, a similar number of horizontal and vertical contours,
the histogram distribution seems initially puzzling. It
reflects a subconscious distortion of where the visual
environment is located. Although we think of the visual
world as a sphere or hemisphere, it is closer to a horizontal
slab of space: most important features are localized close to
the horizon, and the awareness of the large space towards
the ceiling or sky is compressed. The same distortion
accounts probably also for the moon illusion, which is the
powerful impression that the moon is larger close to the
horizon than up in the sky, despite its identical angular
dimensions. An explanation for this illusion is an anisotropy
in visual distance perception (Kaufman and Kaufman,
2000).
The reason for bringing up human psychophysics in
discussing experimental results on mice is to advocate that
the functional significance of the observations described
here ought to be followed up in a species with highly
elaborate vision. While it will be interesting to eventually
examine the retinal phenotype in conditional double null-
mutants for the two enzymes, visual function in mice is far
less specialized and much more difficult to study than in
humans. If our hypothesis is correct that the development of
regions of higher visual acuity depends on locally very low
RA levels in the retina, one wonders whether this might also
apply to the human fovea. It will be interesting to explore
where and when the corresponding CYP26 enzymes are
expressed in the developing human eye. Because the proper
function of the retinoid system depends both on genetic and
environmental factors, disturbances in vitamin-A levels and
RA-dependent genes may play a role not only in early eye
malformations (Hornby et al., 2003), but also in some later
arising ophthalmologic problems.Note added in proof
While this paper was in press, we learned that Ribes,
Petkovich and Dolle´ observed abnormalities in RALDH
expressions in retinas of another Cyp26a1 null-mutant
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